Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Experientia ; 41(1): 72-3, 1985 Jan 15.
Article in English | MEDLINE | ID: mdl-3967741

ABSTRACT

The toxicity of folic acid (PGA) was studied in different inbred strains of mice. LD50 values of PGA by the i.p. route showed a unique toxicity pattern. In some strains, convulsions, ataxia and weakness were observed. Histopathological study in strains S/RVCri, BDF1, DBA/2 and DBA/2fNCri showed acute renal tubular necrosis.


Subject(s)
Folic Acid/toxicity , Animals , Female , Kidney Tubular Necrosis, Acute/chemically induced , Kidney Tubular Necrosis, Acute/pathology , Lethal Dose 50 , Male , Mice , Mice, Inbred AKR , Mice, Inbred C57BL , Mice, Inbred DBA , Mice, Inbred ICR , Mice, Inbred Strains
2.
Chemotherapy ; 30(2): 119-24, 1984.
Article in English | MEDLINE | ID: mdl-6697813

ABSTRACT

Folic acid (FA) was combined with anticancer agents such as (i) antimetabolites like methotrexate (MTX), 5-fluorouracil (5-FU), arabinosyl cytosine (Ara-C) and 6-mercaptopurine (6-MP); (ii) plant-derived mitotic inhibitor, vincristine (VCR), and (iii) an antibiotic, mitomycin C (Mit-C). This combination modality was used for the treatment of P388 lymphocytic leukaemia. Large doses of FA were administered to the tumour-bearing mice either prior to or simultaneously with different anticancer agents. Pre-treatment with FA significantly improved the therapeutic efficacy of 5-FU, Ara-C and Mit-C; while MTX was more effective when given simultaneously with FA. The efficacy of 6-MP and VCR was not enhanced by FA when tested similarly. Large doses of FA can potentiate the activity of certain anticancer agents when administered to P388-bearing mice at critical times that vary according to the particular drug used.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Folic Acid/toxicity , Leukemia P388/drug therapy , Leukemia, Experimental/drug therapy , Animals , Cytarabine/therapeutic use , Drug Evaluation, Preclinical , Drug Synergism , Fluorouracil/therapeutic use , Methotrexate/therapeutic use , Mice , Mitomycins/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...